Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NervGen Pharma Corp. Proxy Solicitation & Information Statement 2025

Mar 3, 2025

47677_rns_2025-03-03_dfc9f2e7-3a07-4d94-94be-660b2e9152cc.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

March 03, 2025

Computershare

510 Burrard St, 3rd Floor

Vancouver BC, V6C 3B9

www.computershare.com

To: All Canadian Securities Regulatory Authorities

Subject: NERVGEN PHARMA CORP.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type : Annual General Meeting
Record Date for Notice of Meeting : March 28, 2025
Record Date for Voting (if applicable) : March 28, 2025
Beneficial Ownership Determination Date : March 28, 2025
Meeting Date : May 06, 2025
Meeting Location (if available) : Toronto, ON
Issuer sending proxy related materials directly to NOBO: Yes
Issuer paying for delivery to OBO: No

Notice and Access (NAA) Requirements:

NAA for Beneficial Holders No
NAA for Registered Holders No

Voting Security Details:

Description CUSIP Number ISIN
COMMON SHARES 64082X203 CA64082X2032

Sincerely,

Computershare

Agent for NERVGEN PHARMA CORP.